Team

Meet the Team

Physiomics’ team comprises passionate specialists with deep expertise in quantitative pharmacology, mathematical modelling, and biostatistics.

Mr Michael Whitlow

Executive Director

Mr Michael Whitlow is an entrepreneur and investor with over 20 years’ experience across small-cap and early-stage companies in multiple sectors and jurisdictions.

Learn more

Mr Nicholas Tulloch

Non-Executive Chair

Mr Nicholas Tulloch has advised companies on the UK capital markets for over 20 years, working for several well-known investment banks and stockbrokers, including Cazenove, Arbuthnot and Cenkos.

Learn more

Mr Ian Bagnall

Finance Director & Company Secretary

Mr Ian Bagnall is a Chartered Accountant with over three decades of experience across corporate finance, operational leadership and investment management. He also holds a BSc in Biochemistry and Physiology.

Learn more

Jesse Thissen

COO & Head of Biometrics

Jesse Thissen brings extensive experience in statistics, clinical development and data-driven decision-making across large pharma, biotech and CRO environments.

Learn more

Hayley Close

Head of Business Development

Hayley Close joins Physiomics with 5 years of business development experience.

Learn more

Dr Frances Brightman

Quantitative Pharmacology Lead

Frances Brightman is a model-informed drug-development specialist, with 25 years of experience.

Learn more

Dr Ghaith Aljayyoussi

Senior Quantitative Pharmacology Scientist

Ghaith is a pharmacokinetics and pharmacodynamics (PK/PD) modelling specialist with experience in both industry and academic environments.

Learn more

Dr Malek Hajjawi

Quantitative Pharmacology Scientist

Malek Hajjawi brings expertise in pharmacometrics, population pharmacokinetic/pharmacodynamic (PK/PD) modelling, physiologically based pharmacokinetic (PBPK) modelling, and model-informed drug development.

Learn more